Food and Drug Administration (FDA) announced on January 28th, 2025, that Ozempic (semaglutide, Novo Nordisk) is now approved to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD)
AgeRejuvenation supports patients across a wide footprint, which matters if you are balancing work schedules, commuting, and family logistics
Don't hesitate to seek expert guidance.
You must be at least 18 years old You have a commercial insurance plan that should or should not cover Mounjaro
Integrating Holistic Weight Management Programs Employers increasingly pair medication coverage with broader wellness initiatives
Proven in RCTs to improve speech, cognition, and behavior in autistic children (Frye et al., 2018)